Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.380
+0.035 (2.60%)
Aug 13, 2026, 4:37 PM CET

Pila Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
61871023857107
Market Cap Growth
-41.48%-14.78%167.21%-33.18%-46.72%-
Enterprise Value
45.5486.69101.7232.1249.7378.71
Last Close Price
1.382.063.751.603.106.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
54.5376.94128.7826.0230.29148.66
PB Ratio
4.205.9219.335.715.983.53
P/TBV Ratio
3.264.8718.157.498.483.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
40.4276.94128.7821.9526.44109.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
----0.89-0.76-0.93
Net Debt / EBITDA Ratio
---0.930.823.05
Net Debt / FCF Ratio
---1.230.803.01
Asset Turnover
0.100.100.110.150.090.04
Quick Ratio
0.090.090.083.475.4918.72
Current Ratio
10.2710.275.213.485.5918.81
Return on Equity (ROE)
-170.82%-170.82%-188.57%-122.66%-134.47%-102.07%
Return on Assets (ROA)
-71.60%-71.60%-110.49%-66.11%-41.64%-49.82%
Return on Invested Capital (ROIC)
-80.71%-80.71%-216.78%-231.75%-268.98%-259.18%
Return on Capital Employed (ROCE)
-80.71%-80.71%-136.03%-78.97%-44.65%-54.93%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-35.92%-35.92%-20.66%-22.29%-31.87%-30.89%
Total Shareholder Return
-35.92%-35.92%-20.66%-22.29%-31.87%-30.89%